It showed that ANXA2 played a general role in most types of cancer, demonstrating its importance in tumor development promotion and led to poor prognosis through epithelial-mesenchymal transition, cancer drug resistance and other pathways (Wang et al., 2019; Huang et al., 2022). This evidence concerns the gene ANXA2 and cancer.